Sign in

NCT07588971Recruiting

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology: Long-term Study

Source: ClinicalTrials.gov · Last updated 15 May 2026

Brief summary (registry, in English)

Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved. The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.

Status (registry)
Recruiting
Study type
Observational
Enrollment
2300 (estimated)
First submitted
2 Mar 2023
Start date
26 Oct 2021
Primary completion date
1 Jan 2027
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT number
NCT07588971

What you commit to

  • Study type: Observational
  • Planned participants: 2300
  • From 26 Oct 2021 to the primary completion date, 1 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with unconfirmed diagnosis of epilepsy after the first critical episode.

Age

  • Patients with follow-up \< 2 years.

Other

  • Patients from other Centers, for whom the history, clinical and instrumental data are not sufficiently detailed and in accordance with the methodologies followed at our Center.
  • Patients for whom study consent is not provided.

Who the study is looking for

  • Patients seen at the Children's Neuropsychiatry of the Fondazione Policlinico Gemelli IRCCS (UOS Diagnosis and Treatment of Drug-Resistant Epilepsies, Day Hospital or inpatient setting at the Department of Children's Neuropsychiatry) with onset of first seizure between the ages of 0 and 18 years and subsequent diagnostic confirmation of epilepsy (2 or more unprovoked seizures at least 24 hours apart or definite epilepsy syndrome, with diagnostic confirmation by the child neuropsychiatrist).
  • Patients already followed at Child Neuropsychiatry with a diagnosis of epilepsy with age of onset between 0 and 18 years.
  • Patients referred to our Center during follow-up with a diagnosis of epilepsy with age of onset between 0 and 18 years.

Age in the registry: - to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coordinator of this site? Confirm its status
RomeItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.